Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,811 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Frameworks for Implementation, Uptake, and Use of Cardiometabolic Disease-Related Digital Health Interventions in Ethnic Minority Populations: Scoping Review.
Ramasawmy M, Poole L, Thorlu-Bangura Z, Chauhan A, Murali M, Jagpal P, Bijral M, Prashar J, G-Medhin A, Murray E, Stevenson F, Blandford A, Potts HWW, Khunti K, Hanif W, Gill P, Sajid M, Patel K, Sood H, Bhala N, Modha S, Mistry M, Patel V, Ali SN, Ala A, Banerjee A. Ramasawmy M, et al. Among authors: patel v, patel k. JMIR Cardio. 2022 Aug 11;6(2):e37360. doi: 10.2196/37360. JMIR Cardio. 2022. PMID: 35969455 Free PMC article. Review.
Prevention of Microvascular Complications of Diabetes.
Crasto W, Patel V, Davies MJ, Khunti K. Crasto W, et al. Among authors: patel v. Endocrinol Metab Clin North Am. 2021 Sep;50(3):431-455. doi: 10.1016/j.ecl.2021.05.005. Endocrinol Metab Clin North Am. 2021. PMID: 34399955 Free article. Review.
Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales.
Holman N, Knighton P, OʼKeefe J, Wild SH, Brewster S, Price H, Patel K, Hanif W, Patel V, Gregg EW, Holt RIG, Gadsby R, Khunti K, Valabhji J, Young B, Sattar N. Holman N, et al. Among authors: patel v, patel k. Diabetes Obes Metab. 2021 Dec;23(12):2728-2740. doi: 10.1111/dom.14528. Epub 2021 Sep 1. Diabetes Obes Metab. 2021. PMID: 34405512
Informing and Empowering Patients and Clinicians to Make Evidence-Supported Outcome-Based Decisions in Relation to SGLT2 Inhibitor Therapies: The Use of the Novel Years of Drug administration (YoDa) Concept.
Varadhan L, Saravanan P, Ali SN, Hanif W, Patel V. Varadhan L, et al. Among authors: patel v. Clin Drug Investig. 2022 Feb;42(2):113-125. doi: 10.1007/s40261-021-01105-7. Epub 2022 Feb 2. Clin Drug Investig. 2022. PMID: 35107773 Free PMC article. Review.
Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19.
Khunti K, Ruan Y, Davies J, Field BCT, Harris S, Kosiborod M, Nagi D, Narendran P, Patel D, Ryder REJ, Várnai KA, Wild SH, Wilmot EG, Rea R; ABCD COVID-19 Diabetes National Audit Investigators. Khunti K, et al. Diabetes Care. 2022 Sep 8:dc220357. doi: 10.2337/dc22-0357. Online ahead of print. Diabetes Care. 2022. PMID: 36074663
5,811 results